Links
Organizations
Conferences
Info & Opinion
July 20, 2008
The V-Word
Merck’s Win, Industry’s Loss
The first class action settlement for Vioxx is good news for Merck but will play out differently for industry.
- Home
- Tag
- stents
Earlier this month, after months of negotiations, Merck announced a large but manageable $4.85 billion settlement of an unknown number of Vioxx plaintiffs who can prove they took the drug and suffered strokes or heart attacks. Those plaintiffs still have…
No articles available
